Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression

Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression (2007)

Authors:
Autor USP: CHAMMAS, ROGER - FM
Unidade: FM
Subjects: METALOPROTEINASES; MELANOMA; PROLIFERAÇÃO CELULAR
Language: Inglês
Imprenta:
- Publisher place: Ribeirão Preto
- Date published: 2007
Source:
- Título: Applied Cancer Research
- ISSN: 1808-5512
- Volume/Número/Paginação/Ano: v. 27, n. 2, p.76, res. PT.088, 2007
Conference titles: São Paulo Research Conference-Cancer

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

COSTA, E. T. et al. Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research, v. 27, n. 2, p. 76, 2007Tradução . . Acesso em: 07 out. 2024.
APA

Costa, E. T., Verbisck, N. V., Chammas, R., Costa, F. F., & Camargo, A. A. (2007). Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research, 27( 2), 76.
NLM

Costa ET, Verbisck NV, Chammas R, Costa FF, Camargo AA. Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research. 2007 ; 27( 2): 76.[citado 2024 out. 07 ]
Vancouver

Costa ET, Verbisck NV, Chammas R, Costa FF, Camargo AA. Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research. 2007 ; 27( 2): 76.[citado 2024 out. 07 ]